Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORAGENICS INC Director's Dealing 2017

Feb 13, 2017

35380_dirs_2017-02-13_91a4d280-5861-449f-a129-adb8783409de.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAGENICS INC (OGEN.BC)
CIK: 0001174940
Period of Report: 2017-02-09

Reporting Person: Telling Fred (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-09 Common Stock A 40000 $0.00 Acquired 1355354 Direct

Footnotes

F1: Represents an award of restricted stock in connection with service to the Company as a director pursuant to the 2012 Equity Incentive Plan that vest equally over each of the four calendar quarters during 2017.